-
Increasing stroke cases in young adults: Reasons for this disturbing trend, treatment tips
02 May 2024 11:52 GMT
… Certain infections such as HIV, Herpes virus infection, COVID-19 … Annu Aggarwal suggested the following treatment:
The first three hours … partially life style, influences its development and evolution in humans. … diet more as a rare treat, then as a daily …
-
Johnson & Johnson submits regulatory applications to European Medicines Agency for TREMFYA® (guselkumab) for treatment of patients with ulcerative colitis and Crohn's disease
01 May 2024 17:12 GMT
… injections or pills (systemic therapy) or phototherapy (treatment using … full Prescribing Information, including Medication Guide for TREMFYA®, … of prescription drugs to the FDA. Visit www.fda.gov… or future events or developments.
EU Clinical Trials …
-
Merck Announces Phase 3 KEYNOTE-811 Trial Met Dual Primary Endpoint of Overall Survival (OS) as First-Line Treatment in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
01 May 2024 11:26 GMT
… .S. Food and Drug Administration (FDA) under accelerated approval … an extensive clinical development program evaluating KEYTRUDA in … treatment. Consider monitoring more frequently as compared to when the drugs … _pi.pdf and Medication Guide for KEYTRUDA at …
-
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon
30 Apr 2024 18:11 GMT
… to close the clinical trial with healthy subjects study … are no drugs currently available for the treatment of RSV infection … C Virus (HCV), Rabies, Herpes Simplex Virus (HSV-1 and … path to typical drug development of any pharmaceutical product is extremely …
-
First animal model for Kaposi sarcoma developed
30 Apr 2024 14:53 GMT
… KSHV, which will enable drug and vaccine development.
Scientists at UNC Lineberger … be crucial for the development of new drugs to treat the disease.
Senior … 1994, the Kaposi sarcoma-associated herpes virus (KSHV) is associated with …
-
DR. PETER CHOW: Immunizing against Alzheimer’s disease a 'no brainer'
03 May 2024 18:38 GMT
… new drugs have been approved by the U.S. FDA, … Calmette–Guérin (BCG) vaccine, developed by Albert Calmette and Camille … called “trained immunity.”
BCG treatment changes the expression of … – COVID vaccines as recommended;
– Herpes Zoster (Shingles) – 2 doses …
-
Viral Vector Process Development and Manufacturing
30 Apr 2024 08:21 GMT
… in gene therapy to treat incurable, inherited genetic … Russian gene-therapy drug for the treatment of peripheral … R2) Pharmaceutical Development, November 2009, https:// www.fda.gov… virus production using recombinant herpes simplex virus type …
-
New Kaposi sarcoma mouse model could be key to drug development
30 Apr 2024 01:54 GMT
… key to the development of new drugs to treat the disease. Kaposi … cofactor. The Kaposi sarcoma-associated herpes virus (KSHV) was discovered … have been focusing on developing animal models that would … others will pursue drug and vaccine development based on a …
-
Kaposi sarcoma discovery could facilitate drug development
29 Apr 2024 21:53 GMT
… key to the development of new drugs to treat the disease. Kaposi … key to the development of new drugs to treat the disease. … cofactor. The Kaposi sarcoma-associated herpes virus (KSHV) was discovered … others will pursue drug and vaccine development based on a …
-
DR. PETER CHOW: Immunizing against Alzheimer’s disease a 'no brainer'
03 May 2024 16:56 GMT
… new drugs have been approved by the U.S. FDA, … Calmette–Guérin (BCG) vaccine, developed by Albert Calmette and Camille … called “trained immunity.”
BCG treatment changes the expression of … – COVID vaccines as recommended;
– Herpes Zoster (Shingles) – 2 doses …